Blood Screening Market Size, Growth, Trends, Statistics, Emerging Technologies, Regional Analysis 20

Industry Report "Blood Screening Market Research Report - Global Forecast till 2023" provides a clear picture of the Current Market Scenario which includes past and estimated future size with respect to value and volume, technological advancement, detail information and strategies of top key players in the industry.

Blood Screening Market Overview

Market Research Future (MRFR) predicts the global blood screening market to achieve a CAGR of 9.8% during the forecast period (2018–2023).

Technological developments help enhance the sensitivity and efficiency of the tests. Case in point, in 2016, the Procleix Zika virus assay developed by Hologic, Inc., and Grifols was approved by the U.S. F.D.A for screening of donated blood. Moreover, in 2013, the U.S. FDA had given approval to the next-generation sequencing (NGS) technology. This technology is low-cost and faster compared to previous DNA analysis methods.

Market Segmentation

The worldwide market for blood screening has been segmented on the technology, products & services and end-users.

Depending on the technology, the market has been classified into nucleic acid amplification test (NAT), enzyme-linked immunosorbent assay (ELISA), rapid tests, next-generation sequencing (NGS), western blotting.

With respect to products and services, the market is considered for reagent and kits, enzymes and polymerases, standards and controls, probes and primers, buffers, nucleotides, and solutions, immunosorbents, instruments and software, and services.

The various end users in the market are hospitals, clinics, research institutes and academic centers, blood banks and others.

Esteemed Vendors

Some of the esteemed vendors highlighted in the report are Abbott Laboratories, Ortho Clinical Diagnostics, Inc., Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche, Beckman Coulter (A Subsidiary of Danaher Corporation), Becton, Dickinson and Company Market Grifols, Biomérieux, Bio-Rad Laboratories, Inc., Siemens Healthineers (A Subsidiary of Siemens AG), to name a few.

Get Detailed Information on Blood Screening Market: By Technology (Nucleic Acid Amplification Test, Enzyme-Linked Immunosorbent Assay, Next-Generation Sequencing), By Product and Services (Reagents, Instruments) and End User (Hospitals and Clinics) — Global Forecast till 2023 @ https://www.marketresearchfuture.com/reports/blood-screening-market-6899

Industry Update

Epigenomics AG reports that Epi proColon, which is a colorectal cancer blood screening test for those that are unable to be screened by conventional methods, could now be a crucial complement to colonoscopy for screening blood of patients with Lichen sclerosus (LS).

Intended Audience:

• Blood Screening Instruments and Reagents Manufacturers
• Blood Screening Software and Services Providers
• Blood Banks
• Hospitals
• Red Cross Societies
• Regulatory Bodies
• Research and Consulting Firms
• Government Bodies

Related News

Blood Screening Market - Global Forecast till 2023

ePharmacy Market -Global Forecast till 2023

About Market Research Future:

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

https://www.marketresearchfuture.com

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Ma